Alisha A. Mohamed-Hadley, Ph.D.
Affiliations: | 2011 | Molecular Biology and Genetics | Temple University, Philadelphia, PA, United States |
Area:
Molecular Biology, Cell BiologyGoogle:
"Alisha Mohamed-Hadley"Parents
Sign in to add mentor| Barbara Hoffman | grad student | 2011 | Temple University | |
| (The role of the stress response gene Gadd45a in modulating Myc mediated apoptosis and differentiation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liebermann DA, Tront JS, Sha X, et al. (2011) Gadd45 stress sensors in malignancy and leukemia. Critical Reviews in Oncogenesis. 16: 129-40 |
| Mohamed-Hadley AA, Liebermann D. (2010) Stress Response Gadd45a Gene Functions as Tumor Suppressor In MYC Expressing Myeloid Cells Modulating Apoptosis and Cytokine Receptor Expression. Blood. 116: 1556-1556 |
| Hoffman B, Mohamed-Hadley A, Liebermann D. (2010) Abstract 3099: Stress response gadd45a gene as tumor suppressor in MYC expressing myeloid cells is cytokine specific Cancer Research. 70: 3099-3099 |
| Mohamed-Hadley AA, Liebermann DA, Hoffman B. (2009) Stress Response Gadd45a Gene as Tumor Suppressor in MYC Expressing Myeloid Cells Is Cytokine Specific. Blood. 114: 1481-1481 |
| Mohamed-Hadley A, Gibbs JD, Liebermann DA, et al. (2007) Gadd45a Behaves as a Tumor Suppressor and Gadd45b Behaves as an Oncogene in myc-Mediated Block in Myeloid Differentiation. Blood. 110: 4163-4163 |
| Gibbs JD, Mohamed-Hadley A, Liebermann DA, et al. (2007) Gadd45 Genes Participate in Myeloid Cell Fate Determination. Blood. 110: 4043-4043 |
| Benencia F, Courrèges MC, Conejo-García JR, et al. (2005) HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 789-802 |
| Conejo-Garcia JR, Benencia F, Courreges MC, et al. (2003) Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biology & Therapy. 2: 446-51 |